Biodesix (BDSX) Current Leases (2022 - 2026)

Biodesix has reported Current Leases for 5 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 32.72% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 32.72% YoY), and the FY2025 full-year result was $1.4 million, up 89.71% from the prior year.
• Current Leases for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
• The five-year high for Current Leases was $1.8 million in Q1 2023, with the low at $252000.0 in Q4 2023.
• Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $1.2 million in 2025.
• Annual changes were most pronounced in 2024 — Current Leases tumbled 84.56% — and 2025, when it jumped 310.67%.
• Biodesix's Current Leases stood at $1.5 million in 2022, then plunged by 83.67% to $252000.0 in 2023, then jumped by 185.32% to $719000.0 in 2024, then surged by 89.71% to $1.4 million in 2025, then advanced by 6.45% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.